SEI Investments’s BeOne Medicines Ltd ONC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.22M | Sell |
4,303
-18
| -0.4% | -$5.3K | ﹤0.01% | 2200 |
|
|
2026
Q1 | $1.28M | Sell |
4,321
-2,336
| -35% | -$756K | ﹤0.01% | 2229 |
|
|
2025
Q4 | $2.02M | Sell |
6,657
-1,169
| -15% | -$383K | ﹤0.01% | 1847 |
|
|
2025
Q3 | $2.67M | Buy |
7,826
+455
| +6% | +$138K | ﹤0.01% | 1581 |
|
|
2025
Q2 | $1.78M | Buy |
7,371
+1,154
| +19% | +$283K | ﹤0.01% | 1696 |
|
|
2025
Q1 | $1.69M | Buy |
6,217
+1,024
| +20% | +$239K | ﹤0.01% | 1701 |
|
|
2024
Q4 | $959K | Sell |
5,193
-7,622
| -59% | -$1.56M | ﹤0.01% | 1962 |
|
|
2024
Q3 | $2.88M | Sell |
12,815
-11,433
| -47% | -$2.06M | ﹤0.01% | 1518 |
|
|
2024
Q2 | $3.46M | Buy |
24,248
+848
| +4% | +$131K | ﹤0.01% | 1387 |
|
|
2024
Q1 | $3.66M | Sell |
23,400
-35,994
| -61% | -$5.8M | 0.01% | 1356 |
|
|
2023
Q4 | $10.7M | Sell |
59,394
-4,450
| -7% | -$805K | 0.02% | 856 |
|
|
2023
Q3 | $11.5M | Sell |
63,844
-7,892
| -11% | -$1.56M | 0.02% | 779 |
|
|
2023
Q2 | $12.8M | Buy |
71,736
+2,927
| +4% | +$674K | 0.02% | 744 |
|
|
2023
Q1 | $14.8M | Buy |
68,809
+54,373
| +377% | +$13M | 0.03% | 663 |
|
|
2022
Q4 | $3.18M | Buy |
14,436
+2,100
| +17% | +$385K | 0.01% | 1253 |
|
|
2022
Q3 | $1.66M | Buy |
12,336
+600
| +5% | +$103K | ﹤0.01% | 1619 |
|
|
2022
Q2 | $1.9M | Buy |
11,736
+6,150
| +110% | +$961K | ﹤0.01% | 1577 |
|
|
2022
Q1 | $1.05M | Hold |
5,586
| – | – | ﹤0.01% | 1797 |
|
|
2021
Q4 | $1.51M | Sell |
5,586
-412
| -7% | -$139K | ﹤0.01% | 1689 |
|
|
2021
Q3 | $2.18M | Sell |
5,998
-445
| -7% | -$145K | ﹤0.01% | 1466 |
|
|
2021
Q2 | $2.21M | Sell |
6,443
-164
| -2% | -$54.3K | ﹤0.01% | 1471 |
|
|
2021
Q1 | $2.3M | Sell |
6,607
-7,594
| -53% | -$2.51M | 0.01% | 1389 |
|
|
2020
Q4 | $3.67M | Sell |
14,201
-2,414
| -15% | -$665K | 0.01% | 1107 |
|
|
2020
Q3 | $4.76M | Buy |
16,615
+6,181
| +59% | +$1.45M | 0.01% | 896 |
|
|
2020
Q2 | $1.97M | Sell |
10,434
-52
| -0.5% | -$8.46K | 0.01% | 1273 |
|
|
2020
Q1 | $1.29M | Buy |
10,486
+681
| +7% | +$106K | ﹤0.01% | 1351 |
|
|
2019
Q4 | $1.63M | Sell |
9,805
-231
| -2% | -$38.4K | ﹤0.01% | 1433 |
|
|
2019
Q3 | $1.23M | Buy |
10,036
+1,401
| +16% | +$186K | ﹤0.01% | 1526 |
|
|
2019
Q2 | $1.07M | Buy |
8,635
+8,490
| +5,855% | +$1.08M | ﹤0.01% | 1581 |
|
|
2019
Q1 | $19K | Buy |
+145
| New | +$19.6K | ﹤0.01% | 2750 |
|
|
2018
Q1 | – | Sell |
-22
| Closed | -$2K | – | 3698 |
|
|
2017
Q4 | $2K | Hold |
22
| – | – | ﹤0.01% | 3143 |
|
|
2017
Q3 | $2K | Buy |
+22
| New | +$1.64K | ﹤0.01% | 3011 |
|
Other funds holding ONC
BBA
SEI Investments's ONC Position: Q2 2026 in Review
SEI Investments reduced its BeOne Medicines Ltd (ONC) stake by 0.42% in Q2 2026, selling an estimated $5.3K and leaving 4,303 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #2200.
SEI Investments first reported a position in ONC in Q3 2017 and has held it in 32 quarters since. The position peaked at $14.8M in Q1 2023. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.
- SEI Investments held 4,303 shares of BeOne Medicines Ltd worth $1.22M as of Q2 2026.
- SEI Investments sold 18 BeOne Medicines Ltd shares in Q2 2026, an estimated $5.3K.
- BeOne Medicines Ltd made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2200 holding.
- SEI Investments first reported a position in BeOne Medicines Ltd in Q3 2017 and has held it in 32 quarters since.
- SEI Investments's BeOne Medicines Ltd position peaked at $14.8M in Q1 2023.
- 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.